| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10071959 | American Journal of Ophthalmology | 2005 | 10 Pages |
Abstract
TA intravitreal injection improves VA and reduces CMT more than MLG, which in triamcinolone-treated eyes does not offer further advantages. Intravitreal TA injection could be used as primary treatment in patients with CME.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Teresio MD, Antonio MD, Alfredo MD,